Search research articles
Contact Us
Filters
Showing results (1-10 of 303) with videos related to
Page
of 31
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
September 21, 2019
Sandra Falkvoll, Sascha Gerdes, Ulrich Mrowietz
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
January 16, 2019
Switch of psoriasis therapy from a fumaric acid ester mixture to dimethyl fumarate monotherapy: Results of a prospective study
Sandra Falkvoll, Sascha Gerdes, Ulrich Mrowietz
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
October 3, 2006
Follicular rash during therapy with erlotinib (Tarceva)
Sascha Gerdes, Ulrich Mrowietz
Journal of the European Academy of Dermatology and Venereology : JEADV
|
April 25, 2026
Could the IL-17 cytokine family be a promising target for the treatment of palmoplantar pustulosis?
Ulrich Mrowietz, Sascha Gerdes
Experimental Dermatology
|
May 13, 2014
Psoriasis: to treat or to manage?
Ulrich Mrowietz, Kirsten Steinz, Sascha Gerdes
Experimental Dermatology
|
January 25, 2011
Adipokines and psoriasis
Sascha Gerdes, Martin Rostami-Yazdi, Ulrich Mrowietz
The Journal of Investigative Dermatology
|
January 6, 2019
Oral Health in Patients with Psoriasis-A Prospective Study
Sirka Woeste, Christian Graetz, Sascha Gerdes, et al.
Dermatology (Basel, Switzerland)
|
September 24, 2014
Systemic treatment with fumaric acid esters in six paediatric patients with psoriasis in a psoriasis centre
Kirsten Steinz, Sascha Gerdes, Silja Domm, et al.
Acta Dermato-Venereologica
|
June 29, 2016
Successful Treatment of Refractory Alopecia Areata Universalis and Psoriatic Arthritis, But Not of Plaque Psoriasis with Tofacitinib in a Young Woman
Ulrich Mrowietz, Sascha Gerdes, Regine Gläser, et al.
Dermatology (Basel, Switzerland)
|
November 14, 2021
Effective and Safe Treatment of Psoriatic Disease with the Anti-IL-23p19 Biologic Tildrakizumab: Results of a Real-World Prospective Cohort Study in Nonselected Patients
Katharina A Drerup, Claudia Seemann, Sascha Gerdes, et al.
Page
of 31
Search research articles
Search
Showing results (1-10 of 303) with videos related to
Sort By:
Page
of 31
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
September 21, 2019
Sandra Falkvoll, Sascha Gerdes, Ulrich Mrowietz
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
January 16, 2019
Switch of psoriasis therapy from a fumaric acid ester mixture to dimethyl fumarate monotherapy: Results of a prospective study
Sandra Falkvoll, Sascha Gerdes, Ulrich Mrowietz
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
October 3, 2006
Follicular rash during therapy with erlotinib (Tarceva)
Sascha Gerdes, Ulrich Mrowietz
Journal of the European Academy of Dermatology and Venereology : JEADV
|
April 25, 2026
Could the IL-17 cytokine family be a promising target for the treatment of palmoplantar pustulosis?
Ulrich Mrowietz, Sascha Gerdes
Experimental Dermatology
|
May 13, 2014
Psoriasis: to treat or to manage?
Ulrich Mrowietz, Kirsten Steinz, Sascha Gerdes
Experimental Dermatology
|
January 25, 2011
Adipokines and psoriasis
Sascha Gerdes, Martin Rostami-Yazdi, Ulrich Mrowietz
The Journal of Investigative Dermatology
|
January 6, 2019
Oral Health in Patients with Psoriasis-A Prospective Study
Sirka Woeste, Christian Graetz, Sascha Gerdes, et al.
Dermatology (Basel, Switzerland)
|
September 24, 2014
Systemic treatment with fumaric acid esters in six paediatric patients with psoriasis in a psoriasis centre
Kirsten Steinz, Sascha Gerdes, Silja Domm, et al.
Acta Dermato-Venereologica
|
June 29, 2016
Successful Treatment of Refractory Alopecia Areata Universalis and Psoriatic Arthritis, But Not of Plaque Psoriasis with Tofacitinib in a Young Woman
Ulrich Mrowietz, Sascha Gerdes, Regine Gläser, et al.
Dermatology (Basel, Switzerland)
|
November 14, 2021
Effective and Safe Treatment of Psoriatic Disease with the Anti-IL-23p19 Biologic Tildrakizumab: Results of a Real-World Prospective Cohort Study in Nonselected Patients
Katharina A Drerup, Claudia Seemann, Sascha Gerdes, et al.
Page
of 31